by Massachusetts General HospitalPET scan of a human brain with Alzheimer's disease. Credit: public domainIn patients with Alzheimer's disease, amyloid-beta protein fragments accumulate i
by Massachusetts General HospitalPET scan of a human brain with Alzheimer's disease. Credit: public domainIn patients with Alzheimer's disease, amyloid-beta protein fragments accumulate i
byAmerican Society for Biochemistry and Molecular BiologyCredit: Pixabay/CC0 Public DomainA new study found higher levels of neurodegeneration in rats that consumed reused deep-fried cooking oil
byAmerican Society for Biochemistry and Molecular BiologyCredit: Pixabay/CC0 Public DomainA new study found higher levels of neurodegeneration in rats that consumed reused deep-fried cooking oil
by Kylie A Steel, Clare MacMahon and Todd Pickering,The ConversationCredit: CC0 Public Domain"Look for the gap!" "Move into space!" "Who's free?"Sound familiar?
by Kylie A Steel, Clare MacMahon and Todd Pickering,The ConversationCredit: CC0 Public Domain"Look for the gap!" "Move into space!" "Who's free?"Sound familiar?
by Elana GotkineThe use of gantenerumab leads to lower amyloid plaque burden at 116 weeks, but is not associated with slower clinical decline among patients with early Alzheimer disease, according to
by Elana GotkineThe use of gantenerumab leads to lower amyloid plaque burden at 116 weeks, but is not associated with slower clinical decline among patients with early Alzheimer disease, according to
byPublic Library of ScienceSugarfly. Artistic rendering generated by DALL.E the prompt used is "The drawing of the fruit fly Drosophila in a dark background in the style of Seurat." Th
byPublic Library of ScienceSugarfly. Artistic rendering generated by DALL.E the prompt used is "The drawing of the fruit fly Drosophila in a dark background in the style of Seurat." Th
by National Institutes of HealthAn experimental drug that may improve memory is now being tested in a Phase 1 safety trial. The compound, BPN14770, was developed by Tetra Discovery Partners, with
by National Institutes of HealthAn experimental drug that may improve memory is now being tested in a Phase 1 safety trial. The compound, BPN14770, was developed by Tetra Discovery Partners, with
by Tamara Bhandari,Washington University School of Medicine in St. LouisA new technique for measuring levels in the brain of amyloid beta, a key protein associated with Alzheimer’s disease, woul
by Tamara Bhandari,Washington University School of Medicine in St. LouisA new technique for measuring levels in the brain of amyloid beta, a key protein associated with Alzheimer’s disease, woul
by University of SheffieldA pioneering study led by researchers from the University of Sheffield is helping to give a voice to children and young adults who are living with a parent with dementia
by University of SheffieldA pioneering study led by researchers from the University of Sheffield is helping to give a voice to children and young adults who are living with a parent with dementia
by University College LondonCredit: Pixabay/CC0 Public DomainPersistently engaging in negative thinking patterns may raise the risk of Alzheimer's disease, finds a new UCL-led study.In the st
by University College LondonCredit: Pixabay/CC0 Public DomainPersistently engaging in negative thinking patterns may raise the risk of Alzheimer's disease, finds a new UCL-led study.In the st
by IOS PressCredit: CC0 Public DomainPeople around the world are living longer, and dementia has consequently become recognized as a public health priority in many countries. The Lancet Commissio
by IOS PressCredit: CC0 Public DomainPeople around the world are living longer, and dementia has consequently become recognized as a public health priority in many countries. The Lancet Commissio